⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030
globenewswire.com
JNJ
MRK
ABBV
ABT
NVS
GSK
AMGN
TEVA
JAGX
LLY
PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director Ready to Announce with Confidence?
newsfilecorp.com
RLMD
JNJ
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
globenewswire.com
NBTX
JNJ
ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasis
prnewswire.com
JNJ
New SPRAVATO® (esketamine nasal spray) data support robust effectiveness and show durable effect for treatment resistant depression in a real-world setting
globenewswire.com
JNJ
Bispecific T-Cell Engagers Market Insights Report (2026-2030) Featuring Strategic Analysis of Pfizer, Johnson & Johnson, Roche, AbbVie, Sanofi and Other Key Players
globenewswire.com
PFE
JNJ
AMGN
ABBV
SNY
REGN
MRK
Pelvic Cancer Induced Hemorrhagic Cystitis Market Poised for Very Strong Growth: Expected to Reach $7.98 Billion by 2030
globenewswire.com
PFE
JNJ
MRK
ABBV
SNY
BMY
AZN
NVS
AMGN
Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players
globenewswire.com
AMGN
BMY
LLY
JNJ
PFE
MRK
ZWS
Stratum Biosciences Secures $2M Seed Round to Accelerate AI-Powered Skin Biology Discovery and Expanded R&D Partnerships
prnewswire.com
NVDA
ARQT
JNJ
Johnson & Johnson’s DARZALEX® (daratumumab) becomes the first oncology injectable approved for administration by patients or caregivers
globenewswire.com
JNJ